Reply to thread

Message

<blockquote data-quote="Jake Rickman" data-source="post: 144492" data-attributes="member: 8521">Hi Jo, Thanks for these suggestions. These are all areas I have not looked at much myself so will do some digging and see about generating an article or two on them in the next couple of weeks. To your point about private healthcare, I am not sure what specifically you mean by the rise in private healthcare. But if you're referring to private health insurance, I would think this is more of a boon for law firms with reputable insurance practices rather than healthcare (or life sciences, as most firms tend to call it). That said, there may be an indirect link between the increase in private healthcare and the growth of the life sciences industry, provided that life science companies like pharmaceutical research businesses have more sales in markets where private healthcare is more prominent. (This is the case in the US). I think the theme of globalisation could be critiqued on the basis that the supply chain crises that ripped through the world last year had many businesses reconsidering the supply and delivery of their goods. As a result, businesses have started reverting to &quot;pre-globalisation&quot; means of supply chain organisation, such as by relying on domestic manufacturers rather. This to me seems like a topic that requires lots of data.</blockquote>

[QUOTE="Jake Rickman, post: 144492, member: 8521"] Hi Jo, Thanks for these suggestions. These are all areas I have not looked at much myself so will do some digging and see about generating an article or two on them in the next couple of weeks. To your point about private healthcare, I am not sure what specifically you mean by the rise in private healthcare. But if you're referring to private health insurance, I would think this is more of a boon for law firms with reputable insurance practices rather than healthcare (or life sciences, as most firms tend to call it). That said, there may be an indirect link between the increase in private healthcare and the growth of the life sciences industry, provided that life science companies like pharmaceutical research businesses have more sales in markets where private healthcare is more prominent. (This is the case in the US). I think the theme of globalisation could be critiqued on the basis that the supply chain crises that ripped through the world last year had many businesses reconsidering the supply and delivery of their goods. As a result, businesses have started reverting to "pre-globalisation" means of supply chain organisation, such as by relying on domestic manufacturers rather. This to me seems like a topic that requires lots of data. [/QUOTE]

Verification

Our company is called, "The Corporate ___ Academy". What is the missing word here?

Search

Search

Reply to thread